慢性阻塞性肺病患者活动表型的决定因素
Yusuke Murakami1, Yoshiaki Minakata1, Mai Kato1
1Department of Respiratory Medicine, National Hospital Organization Wakayama Hospital, Wakayama, 644-0044, Japan.
International journal of chronic obstructive pulmonary disease
|September 6, 2023
概括
运动能力和呼吸困难区分了COPD患者的身体活动水平. 肺功能和氧气水平区分高活动/低静止与低活动/高静止表型.
科学领域:
- 肺部医学 肺部医学
- 运动生理学 运动生理学
- 慢性疾病管理 慢性疾病管理
背景情况:
- 身体活动 (PA) 和久坐行为 (SB) 在治疗慢性阻塞性肺病 (COPD) 中至关重要.
- 了解影响COPD不同PA和SB模式 (表型) 的因素至关重要,但基本上是未知的.
- 以前的研究集中在单独的PA和SB上,而不是它们对COPD患者特征的综合影响.
研究的目的:
- 确定和澄清在患有稳定性COPD的患者中区分四种活动表型的具体因素.
- 调查各种患者特征之间的关联及其独特的身体活动和久坐行为的组合.
主要方法:
- 这项研究包括了216名40岁及以上的COPD稳定患者.
- 研究了26个潜在的影响因素,以确定它们与活动表型的关联.
- 进行了统计分析,以提取显著区分四个定义的活动表型的因素.
主要成果:
- 运动能力和呼吸障碍是区分低和高身体活动群体的关键因素.
- 肺功能和运动诱导的脱度区分高体力活动/低久坐行为和低体力活动/高久坐行为表型.
- 身体质量指数 (BMI),握力,上臂周长和HbA1c在低体力活动/低久坐行为小组与低体力活动/高久坐行为小组相比显著更高.
结论:
- 特定的临床和生理因素可以有效地区分COPD患者的不同活动表型.
- 识别这些决定因素可以帮助根据其独特的活动模式为COPD患者量身定制干预措施.
- 这些发现突出了COPD管理中的疾病状况,身体能力和行为模式之间的复杂相互作用.
相关概念视频
01:22Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:26COPD: Management Using Bronchodilators and Corticosteroids
244
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
244